Search

Your search keyword '"Fernández Fuertes, Fernando"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Fernández Fuertes, Fernando" Remove constraint Author: "Fernández Fuertes, Fernando"
27 results on '"Fernández Fuertes, Fernando"'

Search Results

1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

2. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group

6. Pattern of blood concentrations of 47 elements in two populations from the same geographical area but with different geological origin and lifestyles: Canary Islands (Spain) vs. Morocco

7. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

8. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group

9. Coexisting Myeloproliferative and Lymphoproliferative Neoplasms: A European Multicenter Retrospective Study

11. Use of eltrombopag after romiplostim in primary immune thrombocytopenia

12. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

13. Wilson Disease Prevalence: Discrepancy Between Clinical Records, Registries and Mutation Carrier Frequency

14. Paradoxical Findings in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors: Suboptimal Disease Control Perceived As Satisfactory

15. Fotoféresis extracorpórea y trasplante renal

16. Association between Heavy Metals and Rare Earth Elements with Acute Ischemic Stroke: A Case-Control Study Conducted in the Canary Islands (Spain)

17. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

19. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

20. Wilson Disease Prevalence

21. Contribution of Next Generation Flow (NGF) Cytometry in Primary Immune Thrombocytopenia (ITP): Utility for the Differential Diagnosis with Myelodysplastic Syndromes

22. Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers

23. Effect of Pregnancy on the Clinical Course of ITP Pregnant Women and Their Newborns. Resuts of a Spanish Case Series of 297 Primary ITP Pregnancies

24. Use of eltrombopag after romiplostim in primary immune thrombocytopenia

25. Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia

27. Extracorporeal photopheresis and renal transplantation.

Catalog

Books, media, physical & digital resources